Technological watch
DWK Life Sciences Increases Glass Vial Production Capacity to Meet Increased Market Demand
MILLVILLE, N.J.--(BUSINESS WIRE)--DWK Life Sciences announces the expansion and modernization of its glass vial production facility in Rockwood, TN to meet the increased borosilicate glass vial market demand for vaccines, diagnostics and therapeutics. The company combined new equipment installations with significant improvements to existing equipment to more than double production capacity. With a substantial capital investment into the facility, DWK Life Sciences now operates fully automated production lines and a centralized Class 8 certified clean room. DWK Life Sciences has solidified its position as one of the world’s leading producer of precision glassware for primary packaging containers, addressing the demand for pharmaceutical, biotech and diagnostic applications.
“By converting to state-of-the-art lines, complete with dimensional & cosmetic vision inspection equipment, we’ve increased productivity in the plant and are delivering industry leading quality for glass vials,” said Rick Schwartz, Senior Vice President of Marketing and Sales at DWK Life Sciences.
Specific upgrades to the manufacturing capabilities include the addition of new automated tube loaders with vertical loading capabilities. Using state-of-the-art, automated manufacturing processes and Class 8 Clean Room robotic packing, tubular glass vials and tubes are produced in our ISO 9001 certified facility, operated under AQL methods of inspection. The DWK Life Sciences plant enhancements, at its Rockwood, TN facility, is delivering increased production output, both in product quantity and quality.
For detailed information on how DWK can meet your high demand for vials, contact DWK Life Sciences.
About DWK Life Sciences
DWK Life Sciences is the world’s largest manufacturer and supplier of premium glass, plastics, custom configurations and packaging solutions, combining the strengths of three global leading brands: DURAN®, WHEATON®, and KIMBLE®. The Company’s products and services offer global customers the most comprehensive range of labware for scientific research and analytical applications, as well as solutions for storage and packaging. With a global manufacturing footprint and extensive distribution network, DWK Life Sciences enables customers to accelerate the pace of research, discovery and scientific applications while providing supply chain security.
“By converting to state-of-the-art lines, complete with dimensional & cosmetic vision inspection equipment, we’ve increased productivity in the plant and are delivering industry leading quality for glass vials,” said Rick Schwartz, Senior Vice President of Marketing and Sales at DWK Life Sciences.
Specific upgrades to the manufacturing capabilities include the addition of new automated tube loaders with vertical loading capabilities. Using state-of-the-art, automated manufacturing processes and Class 8 Clean Room robotic packing, tubular glass vials and tubes are produced in our ISO 9001 certified facility, operated under AQL methods of inspection. The DWK Life Sciences plant enhancements, at its Rockwood, TN facility, is delivering increased production output, both in product quantity and quality.
For detailed information on how DWK can meet your high demand for vials, contact DWK Life Sciences.
About DWK Life Sciences
DWK Life Sciences is the world’s largest manufacturer and supplier of premium glass, plastics, custom configurations and packaging solutions, combining the strengths of three global leading brands: DURAN®, WHEATON®, and KIMBLE®. The Company’s products and services offer global customers the most comprehensive range of labware for scientific research and analytical applications, as well as solutions for storage and packaging. With a global manufacturing footprint and extensive distribution network, DWK Life Sciences enables customers to accelerate the pace of research, discovery and scientific applications while providing supply chain security.
This project has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement No 837761.
